[{"address1": "No. 5, Xingdao Ring Road North", "address2": "International Bio Island", "city": "Guangzhou", "zip": "510005", "country": "China", "phone": "86 20 3403 7871", "website": "https://www.brbiotech.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Burning Rock Biotech Limited primarily develops and sells cancer therapy selection tests in the People's Republic of China. It operates through three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS) based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various cancer types, including pan-cancer, lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, and ovarian cancer. Its key products include OncoScreen Focus, a multi-gene tumor mutation co-detection test kit for non-small cell lung cancer (NSCLC) patients; OncoScreen Plus, a pan-cancer test for tissue samples, and OncoCompass, a corresponding test for liquid biopsy samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; and ColonCore, which assesses microsatellite loci related to MSI status and detects mutations in genes associated with gastrointestinal cancers. It also provides CanCatch, a pre-operative ctDNA detection and post-operative minimal residual disease calling for relapsed patients; OncoMaster, an automatic NGS data analysis and report interpretation machine; as well as Magnis BR-customized version of the key products. The company has a development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, IMPACT Therapeutics, Boehringer Ingelheim, and Merck KGaA. Burning Rock Biotech Limited was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China.", "fullTimeEmployees": 674, "companyOfficers": [{"maxAge": 1, "name": "Mr. Yusheng  Han", "age": 45, "title": "Founder, Chairman & CEO", "yearBorn": 1979, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Xiaozhi  Hu", "age": 40, "title": "Senior Director of Finance", "yearBorn": 1984, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zhihong  Zhang", "age": 48, "title": "CTO & Director", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hao  Liu", "age": 50, "title": "Senior Advisor", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.27, "open": 3.24, "dayLow": 3.23, "dayHigh": 3.405, "regularMarketPreviousClose": 3.27, "regularMarketOpen": 3.24, "regularMarketDayLow": 3.23, "regularMarketDayHigh": 3.405, "payoutRatio": 0.0, "beta": 0.745, "forwardPE": -5.862069, "volume": 6261, "regularMarketVolume": 6261, "averageVolume": 40360, "averageVolume10days": 17330, "averageDailyVolume10Day": 17330, "bid": 2.4, "ask": 4.24, "bidSize": 2, "askSize": 2, "marketCap": 36606440, "fiftyTwoWeekLow": 2.18, "fiftyTwoWeekHigh": 7.9, "priceToSalesTrailing12Months": 0.06995561, "fiftyDayAverage": 3.03922, "twoHundredDayAverage": 4.54927, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -112738832, "profitMargins": -0.45593, "floatShares": 48307975, "sharesOutstanding": 9034110, "sharesShort": 41457, "sharesShortPriorMonth": 38221, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0039, "heldPercentInsiders": 0.03918, "heldPercentInstitutions": 0.59860003, "shortRatio": 0.91, "shortPercentOfFloat": 0.0056, "impliedSharesOutstanding": 10388000, "bookValue": 53.133, "priceToBook": 0.06399037, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -238576992, "trailingEps": -3.22, "forwardEps": -0.58, "lastSplitFactor": "1:10", "lastSplitDate": 1715731200, "enterpriseToRevenue": -0.215, "enterpriseToEbitda": 0.625, "52WeekChange": -0.43530977, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 3.4, "recommendationKey": "none", "totalCash": 495144992, "totalCashPerShare": 4.601, "ebitda": -180412256, "totalDebt": 42338000, "quickRatio": 2.661, "currentRatio": 3.017, "totalRevenue": 523280992, "debtToEquity": 7.404, "revenuePerShare": 50.217, "returnOnAssets": -0.1439, "returnOnEquity": -0.37028, "grossProfits": 374107008, "freeCashflow": -7972375, "operatingCashflow": -75579000, "revenueGrowth": 0.059, "grossMargins": 0.71492994, "ebitdaMargins": -0.34477, "operatingMargins": -0.11406, "financialCurrency": "CNY", "symbol": "BNR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Burning Rock Biotech Limited", "longName": "Burning Rock Biotech Limited", "fiftyTwoWeekChangePercent": -43.530975, "earningsTimestampStart": 1749034740, "earningsTimestampEnd": 1749211200, "earningsCallTimestampStart": 1716984000, "earningsCallTimestampEnd": 1716984000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.22, "epsForward": -0.58, "fiftyDayAverageChange": 0.36078, "fiftyDayAverageChangePercent": 0.11870809, "twoHundredDayAverageChange": -1.14927, "twoHundredDayAverageChangePercent": -0.25262734, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "exchange": "NGM", "messageBoardId": "finmb_309457193", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": 3.97554, "regularMarketPrice": 3.4, "corporateActions": [], "postMarketTime": 1751574030, "regularMarketTime": 1751561361, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591968600000, "postMarketChangePercent": -2.0588286, "postMarketPrice": 3.33, "postMarketChange": -0.07000017, "regularMarketChange": 0.13, "regularMarketDayRange": "3.23 - 3.405", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 40360, "fiftyTwoWeekLowChange": 1.22, "fiftyTwoWeekLowChangePercent": 0.559633, "fiftyTwoWeekRange": "2.18 - 7.9", "fiftyTwoWeekHighChange": -4.5, "fiftyTwoWeekHighChangePercent": -0.56962025, "displayName": "Burning Rock Biotech", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]